5 SIMPLE TECHNIQUES FOR COMBRETASTATIN A4

 1 prior routine of chemotherapy for State-of-the-art breast cancer and over the whole trial, past publicity to any FGFR inhibitor, important medical procedures or radiotherapy within 4 weeks previous to initial dose of review procedure and taking potent inhibitors or inducers of CYP3A4 or CYP2D6. Any of the following cardiac requirements preclud